Intra-Pericardial Use of Recombinant Factor VIIa in a Patient With Acute Hemorrhagic Pericardial Effusion Following Transcutaneous Aortic Valve Replacement—A Case Report | Zendy

AI Assistant Blog Pricing

Intra-Pericardial Use of Recombinant Factor VIIa in a Patient With Acute Hemorrhagic Pericardial Effusion Following Transcutaneous Aortic Valve Replacement—A Case Report

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.